EUREKA FORBES LIMITED (EUREKAFORB) financials
EUREKA FORBES LIMITED (EUREKAFORB) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Eureka Forbes Limited is India’s leading health and hygiene brand. Its product portfolio encompasses water purification, vacuum cleaning and air purification.[1]
- Market Cap: ₹6,724Cr.
- Current Price: ₹347
- Stock P/E: 33.6
- ROE: 4.25%
- ROCE: 5.86%
- Book Value: ₹236
- Dividend Yield: 0.00%
- 52W High / Low: ₹668/333
In Jun 2026, EUREKA FORBES LIMITED (EUREKAFORB) reported sales ₹701 Cr and net profit ₹55 Cr.
Annual TTM: sales ₹2,804 Cr, net profit ₹177 Cr.
Shareholding: Promoters 62.55% (Jun 2026), FIIs 13.24% (Jun 2026), DIIs 6.70% (Jun 2026), Government 0.62% (Jun 2026), Public 16.89% (Jun 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 673 | 598 | 613 | 608 | 773 | 645 | 684 | 701 |
| Expenses | 601 | 539 | 535 | 546 | 678 | 578 | 599 | 633 |
| Operating Profit | 72 | 59 | 78 | 61 | 96 | 67 | 85 | 67 |
| OPM % | 11% | 10% | 13% | 10% | 12% | 10% | 12% | 10% |
| Other Income | 6 | 4 | 6 | 7 | 6 | -35 | 5 | 27 |
| Interest | 2 | 1 | 1 | 1 | 2 | 3 | 2 | 1 |
| Depreciation | 14 | 15 | 15 | 16 | 16 | 17 | 20 | 19 |
| Profit before tax | 62 | 47 | 68 | 52 | 83 | 12 | 68 | 74 |
| Tax % | 25% | 26% | 25% | 25% | 26% | 27% | 25% | 26% |
| Net Profit | 47 | 35 | 51 | 39 | 62 | 9 | 51 | 55 |
| EPS in Rs | 2.41 | 1.80 | 2.62 | 1.99 | 3.18 | 0.47 | 2.64 | 2.87 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 16 | 8 | 381 | 2,080 | 2,189 | 2,436 | 2,710 | 2,804 |
| Expenses | 16 | 9 | 363 | 1,949 | 1,997 | 2,173 | 2,400 | 2,488 |
| Operating Profit | -0 | -1 | 18 | 132 | 192 | 263 | 310 | 316 |
| OPM % | -0.5% | -17% | 4.7% | 6% | 9% | 11% | 11% | 11% |
| Other Income | 0 | 0 | 2 | -30 | -7 | 19 | -18 | 2 |
| Interest | 0 | 0 | 4 | 20 | 10 | 6 | 8 | 8 |
| Depreciation | 0 | 0 | 9 | 55 | 53 | 58 | 69 | 72 |
| Profit before tax | -1 | -2 | 7 | 27 | 122 | 219 | 216 | 238 |
| Tax % | 56% | 1% | 59% | 37% | 25% | 25% | 26% | — |
| Net Profit | -1 | -2 | 3 | 17 | 92 | 163 | 160 | 177 |
| EPS in Rs | -1.84 | -3.38 | 0.14 | 0.88 | 4.73 | 8.44 | 8.28 | 9.16 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 193 | 193 | 193 | 193 | 193 |
| Reserves | -2 | -3 | -5 | 3,874 | 3,886 | 4,010 | 4,191 | 4,380 |
| Borrowings | 4 | 2 | 2 | 253 | 139 | 39 | 26 | 29 |
| Other Liabilities | 9 | 7 | 5 | 1,815 | 1,810 | 1,878 | 1,899 | 2,100 |
| Total Liabilities | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,702 |
| Fixed Assets | 0 | 0 | 0 | 5,498 | 5,475 | 5,457 | 5,466 | 5,504 |
| CWIP | 0 | 0 | 0 | 0 | 2 | 1 | 2 | 7 |
| Investments | 0 | 0 | 0 | 87 | 101 | 80 | 84 | 88 |
| Other Assets | 14 | 10 | 7 | 550 | 451 | 582 | 758 | 1,103 |
| Total Assets | 14 | 10 | 7 | 6,135 | 6,029 | 6,120 | 6,310 | 6,702 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | — | 1 | 0 | 37 | 171 | 195 | 226 | 242 |
| Cash from Investing Activity | — | 0 | 0 | 7 | -22 | -35 | -168 | -175 |
| Cash from Financing Activity | — | -1 | -0 | -31 | -150 | -117 | -43 | -22 |
| Net Cash Flow | — | -1 | -0 | 13 | -1 | 43 | 14 | 45 |
| Free Cash Flow | — | 1 | 0 | 33 | 160 | 169 | 170 | 157 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | — | -1,200% | 11% | 212% | 133% | 101% | 83% | 78% |
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.56% | 62.55% |
| FIIs | 12.62% | 12.56% | 12.53% | 14.00% | 13.72% | 13.87% | 13.66% | 13.24% |
| DIIs | 6.67% | 6.60% | 7.01% | 6.35% | 6.38% | 6.45% | 6.16% | 6.70% |
| Government | 0.86% | 0.86% | 0.86% | 0.86% | 0.86% | 0.86% | 0.86% | 0.62% |
| Public | 17.29% | 17.41% | 17.03% | 16.23% | 16.48% | 16.27% | 16.77% | 16.89% |
| No. of Shareholders | 31,628 | 32,453 | 30,683 | 29,638 | 31,459 | 34,159 | 35,383 | 35,406 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 63 | 110 | 147 | 22 | 23 | 27 | 31 |
| Inventory Days | 33 | 90 | 109 | 638 | 91 | 99 | 90 | 119 |
| Days Payable | 143 | 159 | 256 | 549 | 99 | 89 | 69 | 75 |
| Cash Conversion Cycle | 1 | -7 | -37 | 235 | 14 | 33 | 48 | 76 |
| Working Capital Days | -48 | -33 | -105 | -546 | -103 | -87 | -71 | -54 |
| ROCE % | -5% | -4% | -58% | 0% | 2% | 3% | 5% | 6% |
Eureka Forbes Limited
₹6,724Cr.
₹347
₹668/333
33.6
Eureka Forbes Limited is India’s leading health and hygiene brand. Its product portfolio encompasses water purification, vacuum cleaning and air purification.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of EUREKA FORBES LIMITED (EUREKAFORB)?
The reported market capitalisation for EUREKA FORBES LIMITED (EUREKAFORB) is ₹6,724Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of EUREKAFORB?
The current price shown for EUREKA FORBES LIMITED (EUREKAFORB) on Fincrux is ₹347 with a 52-week high/low of ₹668/333.
What is the P/E ratio of EUREKA FORBES LIMITED (EUREKAFORB)?
The stock P/E for EUREKA FORBES LIMITED (EUREKAFORB) is 33.6 on Fincrux, with ROE at 4.25% and ROCE at 5.86%.
What were EUREKAFORB latest quarterly results?
For Jun 2026, EUREKA FORBES LIMITED (EUREKAFORB) reported sales ₹701 Cr and net profit ₹55 Cr (figures in ₹ crore unless noted).
What are EUREKAFORB annual sales and net profit?
For TTM, EUREKA FORBES LIMITED (EUREKAFORB) shows sales of ₹2,804 Cr and net profit of ₹177 Cr on the Fincrux profit & loss statement.
Who owns EUREKA FORBES LIMITED (EUREKAFORB)?
Latest shareholding for EUREKA FORBES LIMITED (EUREKAFORB) on Fincrux: Promoters 62.55% (Jun 2026), FIIs 13.24% (Jun 2026), DIIs 6.70% (Jun 2026), Government 0.62% (Jun 2026), Public 16.89% (Jun 2026).
Where can I find EUREKA FORBES LIMITED (EUREKAFORB) financials?
EUREKA FORBES LIMITED (EUREKAFORB) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show EUREKAFORB balance sheet and cash flow?
Yes. The EUREKA FORBES LIMITED (EUREKAFORB) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.